StockWatch
·
Pharmaceuticals
Clarification26 Aug 2026, 02:52 pm

Biocon Ltd: Mylan Inc. Clarifies Shareholding Disposal Error

AI Summary

Biocon Ltd has received a revised disclosure from Mylan Inc. concerning the sale of 9,19,67,019 equity shares, representing 5.64% of Biocon's equity share capital. Mylan Inc. clarified that the post-disposal shareholding was inadvertently disclosed as 5.64% instead of the correct value of Nil. This filing serves solely to rectify a typographical error in the original disclosure made on July 15, 2026, regarding a sale that occurred on July 14, 2026. All other information in the original disclosure remains unchanged.

Key Highlights

  • Mylan Inc. corrects previous shareholding disclosure for Biocon Ltd.
  • Original disclosure incorrectly stated post-sale holding as 5.64%.
  • Correct post-sale holding is Nil, as all shares were disposed of.
  • The filing is a clarification of a typographical error.
  • No other information in the original disclosure is affected.